Stacey Chapman
Overview
Explore the profile of Stacey Chapman including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
134
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tang X, Lu H, Dooner M, Chapman S, Quesenberry P, Ramratnam B
JCI Insight
. 2018 Apr;
3(7).
PMID: 29618654
Replication competent HIV-1 persists in a subpopulation of CD4+ T lymphocytes despite prolonged antiretroviral treatment. This residual reservoir of infected cells harbors transcriptionally silent provirus capable of reigniting productive infection...
2.
Jais M, Younes N, Chapman S, Cu-Uvin S, Ghosh M
AIDS Res Hum Retroviruses
. 2016 Dec;
33(5):407-409.
PMID: 27903071
No abstract available.
3.
Jais M, Younes N, Chapman S, Cu-Uvin S, Ghosh M
Am J Obstet Gynecol
. 2016 Mar;
215(3):324.e1-324.e10.
PMID: 27026477
Background: Rates of HIV infections are increasing in older adults. Although it is known that the HIV/AIDS epidemics affects women disproportionately, little is known regarding immune functions in the genital...
4.
Taylor L, Foont J, Delong A, Wurcel A, Linas B, Chapman S, et al.
AIDS Patient Care STDS
. 2014 Jan;
28(1):4-9.
PMID: 24428794
United States guidelines endorse one-time HCV antibody screening at HIV diagnosis. Rescreening HCV-seronegative patients on a regular basis is still not policy, although HIV-infected persons have reasonably substantial HCV incidence....
5.
Westbrook M, Garg S, Chapman S, Cu-Uvin S, Tashima K, Taylor L
R I Med J (2013)
. 2013 May;
96(1):21-4.
PMID: 23638454
With the widespread availability of highly active antiretroviral therapy (HAART), and increased life expectancy among HIV-infected individuals, liver-related mortality has emerged as the leading cause of non-AIDS-related death. The incidence...
6.
Venkatesh K, Delong A, Kantor R, Chapman S, Ingersoll J, Kurpewski J, et al.
J Womens Health (Larchmt)
. 2013 Mar;
22(4):330-8.
PMID: 23531097
Objective: To longitudinally assess the association between plasma viral load (PVL) and genital tract human immunodeficiency virus (GT HIV) RNA among HIV-1 infected women changing highly active antiretroviral therapy (HAART)...
7.
Eleanya C, DeLong A, Chapman S, Nijhawan A, Ingersoll J, Caliendo A, et al.
J AIDS Clin Res
. 2011 May;
1(4).
PMID: 21572917
No abstract available.
8.
Taylor L, Bowman S, Chapman S, Zaller N, Stein M, Cioe P, et al.
Drug Alcohol Depend
. 2010 Dec;
116(1-3):233-7.
PMID: 21177046
Background: A minority of HIV/HCV coinfected patients with opiate addiction undergo HCV treatment. HCV therapy for HCV-monoinfected methadone maintenance (MM) recipients is safe and effective. We evaluated treatment efficacy and...
9.
McGovern B, Ditelberg J, Taylor L, Gandhi R, Christopoulos K, Chapman S, et al.
Clin Infect Dis
. 2006 Jun;
43(3):365-72.
PMID: 16804853
Background: We conducted a study to determine the prevalence and factors associated with hepatic steatosis in human immunodeficiency virus (HIV)-seropositive patients with hepatitis C and to investigate whether steatosis is...
10.
Blackard J, Komurian-Pradel F, Perret M, Sodoyer M, Smeaton L, St Clair J, et al.
J Med Virol
. 2005 Dec;
78(2):202-7.
PMID: 16372286
HIV co-infection is associated with reduced HCV treatment response rates and accelerated HCV-related liver disease. Cytokines play an important role in regulating hepatic inflammation and fibrogenesis during chronic HCV infection,...